Literature DB >> 17602722

Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior.

W Chen1, F Li, L Mead, H White, J Walker, D A Ingram, A Roman.   

Abstract

One of the requirements for tumor growth is the ability to recruit a blood supply, a process known as angiogenesis. Angiogenesis begins early in the progression of cervical disease from mild to severe dysplasia and on to invasive cancer. We have previously reported that expression of human papillomavirus type 16 E6 and E7 (HPV16 E6E7) proteins in primary foreskin keratinocytes (HFKs) decreases expression of two inhibitors and increases expression of two angiogenic inducers [Toussaint-Smith, E., Donner, D.B., Roman, A., 2004. Expression of human papillomavirus type 16 E6 and E7 oncoproteins in primary foreskin keratinocytes is sufficient to alter the expression of angiogenic factors. Oncogene 23, 2988-2995]. Here we report that HPV-induced early changes in the keratinocyte phenotype are sufficient to alter endothelial cell behavior both in vitro and in vivo. Conditioned media from HPV16 E6E7 expressing HFKs as well as from human cervical keratinocytes containing the intact HPV16 were able to stimulate proliferation and migration of human microvascular endothelial cells. In addition, introduction of the conditioned media into immunocompetent mice using a Matrigel plug model resulted in a clear angiogenic response. These novel data support the hypothesis that HPV proteins contribute not only to the uncontrolled keratinocyte growth seen following HPV infection but also to the angiogenic response needed for tumor formation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17602722      PMCID: PMC2043482          DOI: 10.1016/j.virol.2007.05.030

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  31 in total

1.  Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.

Authors:  M Nees; J M Geoghegan; T Hyman; S Frank; L Miller; C D Woodworth
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

2.  Cervical keratinocytes containing stably replicating extrachromosomal HPV-16 are refractory to transformation by oncogenic H-Ras.

Authors:  Kristi L Berger; Felicia Barriga; Michael J Lace; Lubomir P Turek; Gideon J Zamba; Frederick E Domann; John H Lee; Aloysius J Klingelhutz
Journal:  Virology       Date:  2006-08-30       Impact factor: 3.616

Review 3.  The causal relation between human papillomavirus and cervical cancer.

Authors:  F X Bosch; A Lorincz; N Muñoz; C J L M Meijer; K V Shah
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

4.  Neurofibromas in NF1: Schwann cell origin and role of tumor environment.

Authors:  Yuan Zhu; Pritam Ghosh; Patrick Charnay; Dennis K Burns; Luis F Parada
Journal:  Science       Date:  2002-05-03       Impact factor: 47.728

Review 5.  Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.

Authors:  H zur Hausen
Journal:  J Natl Cancer Inst       Date:  2000-05-03       Impact factor: 13.506

6.  Down regulation of the interleukin-8 promoter by human papillomavirus type 16 E6 and E7 through effects on CREB binding protein/p300 and P/CAF.

Authors:  Shih-Min Huang; D J McCance
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

7.  Epidemiologic classification of human papillomavirus types associated with cervical cancer.

Authors:  Nubia Muñoz; F Xavier Bosch; Silvia de Sanjosé; Rolando Herrero; Xavier Castellsagué; Keerti V Shah; Peter J F Snijders; Chris J L M Meijer
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

8.  Selective silencing of viral gene expression in HPV-positive human cervical carcinoma cells treated with siRNA, a primer of RNA interference.

Authors:  Ming Jiang; Jo Milner
Journal:  Oncogene       Date:  2002-09-05       Impact factor: 9.867

9.  Telomerase activation in cervical keratinocytes containing stably replicating human papillomavirus type 16 episomes.

Authors:  Daniel L Sprague; Stacia L Phillips; Calista J Mitchell; Kristi L Berger; Michael Lace; Lubomir P Turek; Aloysius J Klingelhutz
Journal:  Virology       Date:  2002-09-30       Impact factor: 3.616

10.  Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells.

Authors:  Rosa Anna DeFilippis; Edward C Goodwin; Lingling Wu; Daniel DiMaio
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

View more
  21 in total

1.  Plasmid-based E6-specific siRNA and co-expression of wild-type p53 suppresses the growth of cervical cancer in vitro and in vivo.

Authors:  Xin Li; Yang Li; Jiadi Hu; Bo Wang; Lijing Zhao; Kun Ji; Baofeng Guo; Di Yin; Yanwei Du; Dennis J Kopecko; Dhananjaya V Kalvakolanu; Xuejian Zhao; Deqi Xu; Ling Zhang
Journal:  Cancer Lett       Date:  2013-02-20       Impact factor: 8.679

Review 2.  Persistence of human papillomavirus infection: keys to malignant progression.

Authors:  Jason Bodily; Laimonis A Laimins
Journal:  Trends Microbiol       Date:  2010-11-01       Impact factor: 17.079

3.  Human papillomaviruses as therapeutic targets in human cancer.

Authors:  Karin Hellner; Karl Münger
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

4.  Expression of human papillomavirus type 16 E7 is sufficient to significantly increase expression of angiogenic factors but is not sufficient to induce endothelial cell migration.

Authors:  Joanna Walker; Lucy Clare Smiley; David Ingram; Ann Roman
Journal:  Virology       Date:  2010-12-14       Impact factor: 3.616

Review 5.  The Interaction Between Human Papillomaviruses and the Stromal Microenvironment.

Authors:  B Woodby; M Scott; J Bodily
Journal:  Prog Mol Biol Transl Sci       Date:  2016-10-11       Impact factor: 3.622

6.  Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases.

Authors:  Jason M Bodily; Kavi P M Mehta; Laimonis A Laimins
Journal:  Cancer Res       Date:  2010-12-08       Impact factor: 12.701

7.  Hypoxia-specific stabilization of HIF-1alpha by human papillomaviruses.

Authors:  Mitsuhiro Nakamura; Jason M Bodily; Melanie Beglin; Satoru Kyo; Masaki Inoue; Laimonis A Laimins
Journal:  Virology       Date:  2009-03-24       Impact factor: 3.616

Review 8.  Human viral oncogenesis: a cancer hallmarks analysis.

Authors:  Enrique A Mesri; Mark A Feitelson; Karl Munger
Journal:  Cell Host Microbe       Date:  2014-03-12       Impact factor: 21.023

9.  The RB tumor suppressor positively regulates transcription of the anti-angiogenic protein NOL7.

Authors:  Tanmayi P Mankame; Mark W Lingen
Journal:  Neoplasia       Date:  2012-12       Impact factor: 5.715

Review 10.  Oncogenic activities of human papillomaviruses.

Authors:  Margaret E McLaughlin-Drubin; Karl Münger
Journal:  Virus Res       Date:  2009-06-18       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.